Home › NDC Lookup › RxCUI directory › RxCUI 208094

Sucralfate 100 MG/ML Oral Suspension [Carafate] — RxCUI 208094

RxNorm drug concept · Semantic branded drug
RxCUI 208094 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI208094
Official nameSucralfate 100 MG/ML Oral Suspension [Carafate]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCarafate 100 MG/ML Oral Suspension; Carafate 1 GM in 10 mL Oral Suspension; Carafate 1 GM per 10 ML Oral Suspension
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)316 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sucralfate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats an active duodenal ulcer, which is a sore in the first part of your small intestine. Treatment usually lasts up to 8 weeks. The tablets can also be used at a lower dose t...
  • Take it by mouth on an empty stomach, as your prescriber directs. For an active ulcer, the label describes four doses a day. Keep going for the full course even if you feel better,...
  • Yes, for pain relief if your doctor allows. Just keep them at least 30 minutes before or after your sucralfate dose.
  • Constipation is the most common one, though most people have no trouble. Some get nausea, diarrhea, dry mouth, dizziness or a rash. Call your doctor if something bothers you or doe...
📖 Read our full Sucralfate guide →

🕸️ Concept Web — How Sucralfate 100 MG/ML Oral Suspension [Carafate] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sucralfate 100 MG/ML Oral Suspension [Carafate] RxCUI 208094

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sucralfate 10156
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Carafate 227743
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sucralfate Oral Suspension 373966
    • Sucralfate Oral Liquid Product 1161767
    • Sucralfate Oral Product 1161768
    • Sucralfate Oral Suspension [Carafate] 365868
    • Carafate Oral Liquid Product 1173681
    • Carafate Oral Product 1173682
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sucralfate 100 MG/ML Oral Suspension SCD · 313123
  • Sucralfate 100 MG/ML SCDC · 316737
  • Sucralfate Oral Suspension SCDF · 373966
  • Sucralfate Oral Liquid Product SCDG · 1161767
  • Sucralfate Oral Product SCDG · 1161768

Brand-Name Concepts

  • Sucralfate 100 MG/ML [Carafate] SBDC · 568822
  • Sucralfate Oral Suspension [Carafate] SBDF · 365868
  • Carafate Oral Liquid Product SBDG · 1173681
  • Carafate Oral Product SBDG · 1173682
  • Carafate BN · 227743

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 208094 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58914-0170-14 420 mL in 1 BOTTLE (58914-170-14) Carafate Allergan, Inc. 1993-12-16
58914-0170-60 6 CUP, UNIT-DOSE in 1 BOX (58914-170-60) / 10 mL in 1 CUP,... Carafate Allergan, Inc. 1993-12-16
Observed labelers: Allergan, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.